NEW YORK – Which articles gained the most interest from GenomeWeb readers last week? Here are the top five:
- EU to Disallow Illumina's Grail Purchase
- Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain
- Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence
- Liquid Biopsy Tool Detects Epigenetic Signs of Cancer From Cell-Free DNA
- Whole-Genome Liquid Biopsy Method Discerns Cancer-Associated Mutational Signatures